Werner Scheuer
22Patents
7h-index
44Co-inventors
69Inventor score
Filing activity: Jun 26, 1995 → Jan 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8268314B2 | Bispecific anti-VEGF/anti-ANG-2 antibodies | Chemistry; Metallurgy | 49 | Active |
| US8529901B2 | Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label | Human Necessities | 18 | Active |
| US8703130B2 | Bispecific anti-VEGF/anti-ANG-2 antibodies | Chemistry; Metallurgy | 17 | Active |
| US9687568B2 | Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label | Human Necessities | 13 | Active |
| US8133979B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 13 | Active |
| US9090700B2 | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 | Chemistry; Metallurgy | 12 | Active |
| US9708396B2 | Bispecific anti-VEGF/anti-ANG-2 antibodies | Chemistry; Metallurgy | 12 | Active |
| US8361747B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 7 | Active |
| US5716983A | Use of coumarins and carbostyrils as PLA.sub.2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents | Chemistry; Metallurgy | 7 | Expired |
| US8907069B2 | Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent | Chemistry; Metallurgy | 6 | Active |
| US9050375B2 | Bi-specific digoxigenin binding antibodies | Chemistry; Metallurgy | 5 | Active |
| US8399626B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 4 | Active |
| US5767249A | Monoclonal antibodies against type I phospholipase A.sub.2 as a diagnostic and anti-inflammatory therapeutic agent | Chemistry; Metallurgy | 2 | Expired |
| US9340609B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 2 | Active |
| US10584178B2 | Bispecific HER2 antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9109027B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 1 | Active |
| US9574016B2 | Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent | Chemistry; Metallurgy | 0 | Active |
| US5856325A | Benzotriazines, pharmaceutical compositions, and methods of using same | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11787873B2 | Bispecific HER2 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9073986B2 | Antibodies against human angiopoietin 2 | Chemistry; Metallurgy | 0 | Active |
| US5696155A | Dibenzb,e!oxepin derivatives and pharmaceutical agents which contain them | Chemistry; Metallurgy | 0 | Expired |
| US9339560B2 | Method for determining the anti-tumor efficacy of monoclonal antibodies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.